Share this article and save a life!
Healthcare AI just pulled in $100M+ this week. Here’s who got funded.
$77 million to Iterative Health (Series C)
$12 million to Lungpacer Medical (Convertible Note)
$3 million to TietAI (Seed)
$1 million to Depth Health (Seed)
These aren’t random bets.
Look at where the smart money is flowing:
🎯 Clinical AI that actually works
🎯 B2B software replacing broken systems
🎯 Hardware solving real patient problems
The standout? Iterative Health’s massive Series C.
They’re not building another chatbot. They’re tackling precision medicine with AI that helps gastroenterologists catch early stage diseases.
Remember when we hit $29.7 billion in global digital health funding last year?
We’re on track to beat it.
Q1 2026 alone saw $3 billion across 122 deals. That’s investor confidence despite economic headwinds.
But here’s what’s different this time:
Investors want clinical validation, not promises.
They want infrastructure, not apps.
They want ROI within 18 months.
Notice what’s NOT getting funded?
❌ Direct to consumer wellness apps
❌ Me-too telehealth platforms
❌ Solutions looking for problems
The message is clear: Build something hospitals will actually pay for.
Early stage startups like TietAI (Spain) and YStory (Japan) securing seed rounds proves global appetite for healthcare innovation remains strong.
Even convertible notes like Lungpacer’s $12M show creative funding structures are keeping innovation alive.
For healthcare executives watching this space:
These startups will be knocking on your door in 12 months.
Some will transform your operations.
Some will waste your time.
The difference? Look at their investors.
Boehringer Ingelheim backing Click Therapeutics tells you pharma sees digital therapeutics as real medicine.
CSS Insurance launching a CHF 400,000 grant pool tells you payers want preventive care innovation.
The average US digital health startup has raised $110.8 million.
That’s not experimentation money.
That’s transformation money.
Your vendors are getting acquired.
Your competitors are partnering with startups.
Your workforce expects modern tools.
The question isn’t whether to engage with healthcare startups.
It’s how fast you can evaluate them.
♻️ Repost if healthcare needs more smart capital, not just more capital
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
